Literature DB >> 18272392

Extracellular tau promotes intracellular calcium increase through M1 and M3 muscarinic receptors in neuronal cells.

A Gómez-Ramos1, M Díaz-Hernández, A Rubio, M T Miras-Portugal, J Avila.   

Abstract

Extracellular tau promotes an increase in the level of intracellular calcium in cultured neuronal cells. We have found that such increase is impaired in the presence of antagonists of muscarinic receptors. In order to identify the nature of those receptors, we have tested the effect of different specific muscarinic receptor antagonists on tau promoted calcium increase. Our results indicate that the increase does not take place in the presence of antagonists of muscarinic (mainly M1 and M3) receptors. A similar increase in intracellular calcium was found in non-neuronal cells transfected with cDNA of M1 and M3 muscarinic receptors when tau was added. These results suggest that observed effect of tau protein on neuronal (neuroblastoma and primary cultures of hippocampal and cortical neurons) cells is through M1 and M3 muscarinic receptors. Therefore blocking M1 and for M3 receptors, by using specific receptor antagonists, can prevent that tau toxic effect that could take place in tauopathies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18272392     DOI: 10.1016/j.mcn.2007.12.010

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  100 in total

Review 1.  Targeting tau protein in Alzheimer's disease.

Authors:  Cheng-Xin Gong; Inge Grundke-Iqbal; Khalid Iqbal
Journal:  Drugs Aging       Date:  2010-05       Impact factor: 3.923

Review 2.  Actin dynamics and cofilin-actin rods in alzheimer disease.

Authors:  James R Bamburg; Barbara W Bernstein
Journal:  Cytoskeleton (Hoboken)       Date:  2016-03-01

3.  Protein τ-mediated effects on rat hippocampal choline transporters CHT1 and τ-amyloid β interactions.

Authors:  Zdena Kristofikova; Daniela Ripova; Katerina Hegnerová; Jana Sirova; Jiri Homola
Journal:  Neurochem Res       Date:  2013-07-04       Impact factor: 3.996

Review 4.  Tau-focused immunotherapy for Alzheimer's disease and related tauopathies.

Authors:  Einar M Sigurdsson
Journal:  Curr Alzheimer Res       Date:  2009-10       Impact factor: 3.498

5.  In vivo microdialysis reveals age-dependent decrease of brain interstitial fluid tau levels in P301S human tau transgenic mice.

Authors:  Kaoru Yamada; John R Cirrito; Floy R Stewart; Hong Jiang; Mary Beth Finn; Brandon B Holmes; Lester I Binder; Eva-Maria Mandelkow; Marc I Diamond; Virginia M-Y Lee; David M Holtzman
Journal:  J Neurosci       Date:  2011-09-14       Impact factor: 6.167

6.  Cholinergic Mechanisms in the Cerebral Cortex: Beyond Synaptic Transmission.

Authors:  Saak V Ovsepian; Valerie B O'Leary; Laszlo Zaborszky
Journal:  Neuroscientist       Date:  2015-05-22       Impact factor: 7.519

7.  Reversal of Calcium Dysregulation as Potential Approach for Treating Alzheimer's Disease.

Authors:  Elena Popugaeva; Daria Chernyuk; Ilya Bezprozvanny
Journal:  Curr Alzheimer Res       Date:  2020       Impact factor: 3.498

8.  The tau code.

Authors:  Jesús Avila
Journal:  Front Aging Neurosci       Date:  2009-07-30       Impact factor: 5.750

9.  Propagation of tau misfolding from the outside to the inside of a cell.

Authors:  Bess Frost; Rachel L Jacks; Marc I Diamond
Journal:  J Biol Chem       Date:  2009-03-11       Impact factor: 5.157

Review 10.  Chronic traumatic encephalopathy-integration of canonical traumatic brain injury secondary injury mechanisms with tau pathology.

Authors:  Jacqueline R Kulbe; Edward D Hall
Journal:  Prog Neurobiol       Date:  2017-08-26       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.